Nuzenio

Bio Announces

Bio Announces news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 19 latest news signals 11 publisher sources 100/100 entity strength

Latest news

Press Release: Braveheart Bio Announces Closing of Upsized Initial Public Offering Including Full Exercise of Underwriters' Option to Purchase Additional Shares - MoomooMoomoo · Fri, 07 Aug 2026 20:05:00 GMT Braveheart Bio Shares Begin Nasdaq Trading After $439.9M IPO - Stock TitanStock Titan · Fri, 07 Aug 2026 20:05:00 GMT INmune Bio Inc. Announces Second Quarter 2026 Results and Highlights Regulatory, Manufacturing and Clinical Progress - Yahoo FinanceYahoo Finance · Thu, 06 Aug 2026 20:00:00 GMT Press Release: INmune Bio Inc. Announces Second Quarter 2026 Results and Highlights Regulatory, Manufacturing and Clinical Progress - MoomooMoomoo · Thu, 06 Aug 2026 20:00:00 GMT Dispatch Bio Announces First Patient Dosed in Phase 1 Study of DISP-10, a Novel Investigational Immunotherapy, in Advanced Gastrointestinal (GI) Cancers - Yahoo FinanceYahoo Finance · Thu, 06 Aug 2026 12:00:00 GMT Braveheart Bio Expects Nasdaq Debut Aug. 6 After $18 IPO - Stock TitanStock Titan · Thu, 06 Aug 2026 02:36:06 GMT TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Yahoo FinanceYahoo Finance · Wed, 05 Aug 2026 20:05:00 GMT TELA Bio’s New CEO and 11 New Hires Get Stock Grants - Stock TitanStock Titan · Wed, 05 Aug 2026 20:05:00 GMT

Timeline

Fri, 07 Aug 2026 20:05:00 GMTPress Release: Braveheart Bio Announces Closing of Upsized Initial Public Offering Including Full Exercise of Underwriters' Option to Purchase Additional Shares - Moomoo

Fri, 07 Aug 2026 20:05:00 GMTBraveheart Bio Shares Begin Nasdaq Trading After $439.9M IPO - Stock Titan

Thu, 06 Aug 2026 20:00:00 GMTINmune Bio Inc. Announces Second Quarter 2026 Results and Highlights Regulatory, Manufacturing and Clinical Progress - Yahoo Finance

Thu, 06 Aug 2026 20:00:00 GMTPress Release: INmune Bio Inc. Announces Second Quarter 2026 Results and Highlights Regulatory, Manufacturing and Clinical Progress - Moomoo

Thu, 06 Aug 2026 12:00:00 GMTDispatch Bio Announces First Patient Dosed in Phase 1 Study of DISP-10, a Novel Investigational Immunotherapy, in Advanced Gastrointestinal (GI) Cancers - Yahoo Finance

Thu, 06 Aug 2026 02:36:06 GMTBraveheart Bio Expects Nasdaq Debut Aug. 6 After $18 IPO - Stock Titan

Related explainers

ElectionsElection stories need careful handling because polls, turnout, legal challenges, and campaign claims can change quickly.HealthHealth stories help readers understand public-health signals, medical research, hospital systems, medicines, disease updates, and safety guidance.HealthcareHealthcare stories can affect personal decisions, so Nuzenio treats them as information that should be checked with original sources and professionals.

Connected entities

Announces Second Quarter4 live mentions Results4 live mentions Highlights Regulatory4 live mentions Manufacturing4 live mentions After3 live mentions INmune Bio Inc3 live mentions Appointment3 live mentions Press Release2 live mentions Braveheart Bio Announces2 live mentions Closing2 live mentions

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Bio Announces.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

11 distinct publisher/source names are currently connected to this entity page.